WellGen proceeds to build pipeline of patented nutraceuticals and advance product development programs.
Publication Date: 01-SEP-07
Publication Title: BIOTECH Patent News
Format: Online

Read this article now
Try Goliath Business News - FREE!
You can view this article PLUS...

  • Over 5 million business articles
  • Hundreds of the most trusted magazines, newswires, and journals (see list)
  • Premium business information that is timely and relevant
  • Unlimited Access

Now for a Limited Time, try Goliath Business News
Free for 7 Days!

Tell Me More   Terms and Conditions

Purchase this article for $4.95

Description

WellGen, Inc. (North Brunswick, NJ), a biotechnology company using nutrigenomics to discover and develop food ingredients for wellness products, announced the completion of its Series C financing totaling $9.5 million. The capital raised from this round of financing will enable WellGen to advance its anti-obesity ingredient for functional foods, including the launch of a human study that has already received Institutional Review Board approval, and to conduct further...



More articles from BIOTECH Patent News
University of Southern California obtains United States patent., September 01, 2007
Celtrix obtains United States patent., September 01, 2007
Monsanto obtains United States patent., September 01, 2007
ProChon obtains United States patent., September 01, 2007
Degussa obtains United States patent., September 01, 2007

Looking for additional articles?
Click here to search our database of over 3 million articles.